Inhibition of insulin‐like growth factor 2 <scp>mRNA</scp> ‐binding protein 1 sensitizes colorectal cancer cells to chemotherapeutics-Reference-Cited by-同舟云学术

Inhibition of insulin‐like growth factor 2 mRNA ‐binding protein 1 sensitizes colorectal cancer cells to chemotherapeutics

Published:2022-10-05 Issue:12 Volume:4 Page:816-829
ISSN:2573-9832
Container-title:FASEB BioAdvances
language:en
Short-container-title:FASEB BioAdvances

Author:

Betson Nicole¹,Hajahmed Mohammed¹,Gebretsadek Tsige¹,Ndebele Kenneth¹,Ahmad H. Anwar¹²,Tchounwou Paul B.¹²^ORCID,Spiegelman Vladimir S.³,Noubissi Felicite K.¹²^ORCID

Affiliation:

1. Department of Biology Jackson State University Jackson Mississippi USA

2. Research Centers in Minority Institutions (RCMI), Center for Health Disparity Research (RCMI‐CHDR) Jackson State University Jackson Mississippi USA

3. Division of Pediatric Hematology/Oncology Pennsylvania State University, Hershey Medical Center Hershey Pennsylvania USA

Funder

National Institute on Minority Health and Health Disparities

Publisher

Wiley

Subject

Cancer Research,Biochemistry, Genetics and Molecular Biology (miscellaneous),Molecular Medicine,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fba.2021-00069

Reference39 articles.

1. Colorectal Cancer Model of Health Disparities: Understanding Mortality Differences in Minority Populations

2. Eliminating Racial Disparities in Colorectal Cancer in the Real World: It Took a Village